Etizolam bulk supplier for pharma manufacturers

Etizolam 0.25 mg, 0.5 mg, 1 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.25 mg, 0.5 mg, 1 mg

Reference Brands: Depas®, Etilaam®, Etizest®(India & Japan)

Etizolam, available in 0.25 mg to 1 mg tablets, is a fast-acting anxiolytic used for anxiety and insomnia. Though unapproved in the US/EU, it’s widely marketed in Asia under brands like Depas® and Etilaam®. Pharma B2B buyers can procure bulk Etizolam from GMP-approved, export-ready manufacturers.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Etizolam is a thienodiazepine used for short-term treatment of anxiety, panic attacks, and insomnia. Though structurally similar to benzodiazepines, it offers rapid onset and fewer tolerance issues. Commonly available in 0.25 mg, 0.5 mg, and 1 mg tablets, Etizolam is widely marketed in Asian countries but is not FDA-approved in the US or broadly available in the EU. Brands include Depas®, Etilaam®, and Etizest®. Pharma B2B buyers can source Etizolam in bulk from GMP-certified facilities for regulated international markets. Ideal for psychiatric distributors and generic exporters seeking consistent supply of anxiolytic APIs or formulations.

Etizolam — third party manufacturing & bulk supply

Etizolam 0.25 mg, 0.5 mg, 1 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Etizolam is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Etizolam listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Etizolam →

Back to Listing

Frequently Asked Questions

Etizolam is listed as Tablets in 0.25 mg, 0.5 mg, 1 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Etizolam is referenced against Depas®, Etilaam®, Etizest®(India & Japan). Reference brands are shown for identification only and remain the property of their respective trademark owners.